BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,835.00
-5.00 (-0.10%)
At close: Aug 21, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 489.26 billion as of August 21, 2026. Its market cap has decreased by -15.32% in one year.
Market Cap
489.26B
Enterprise Value
124.20B
Revenue
126.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,835.00
ChartMarket Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 489.26B, a decrease of -54.91%. That is a compound annual growth rate of -19.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 489.26B | -11.76% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 2.10T |
| L&C BIO Co.,LTD | 1.38T |
| SD Biosensor | 708.15B |
| T&L Co., Ltd. | 476.22B |
| Samyang Biopharm | 437.23B |
| Vieworks | 230.99B |
| Shinhung | 129.55B |
| EOFLOW | 51.11B |